| 摘要 |
<p>This invention relates to a method of determining the most efficacious and safe drug for a population of subjects to modulate a gene or gene product (e.g., protein or polypeptide) by determining the nucleic acid sequence of all or a portion of a gene and/or all or a portion of the encoded amino acid sequence of that gene with the lowest frequency of polymorphisms.</p> |
